2nd Quarter - Report

W STRATEGIES, LLC for GLAXOSMITHKLINE

Period 2nd Quarter 2020 Filed Jul 20, 2020 Signed by Darren Willcox

Official filing
Firm
W STRATEGIES, LLC
Client
GLAXOSMITHKLINE
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Proposed legislation around FDA cosmetics reform. H.R.1425: Patient Protection and Affordable Care Enhancement Act. Education around COVID-19 vaccines.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1425 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.